Literature DB >> 7626717

Infertility in transgenic mice overexpressing the bovine growth hormone gene: luteal failure secondary to prolactin deficiency.

M Cecim1, J Kerr, A Bartke.   

Abstract

Overexpression of growth hormone (GH) in transgenic mice is associated with various degrees of impairment of female reproductive functions. Transgenic PEPCK.bGH mice express high GH levels, and only around 20% of the females will carry gestation to Day 7. The objective of the present study was to investigate luteal function in PEPCK.bGH mice during early pregnancy, when CL are fully dependent on the pituitary. Plasma progesterone levels measured on Days 2 or 7 postcoitum (p.c.) were lower in transgenic than in normal females. In transgenic females with a previous history of infertility, daily injections of 1 mg progesterone starting on Day 2 p.c. significantly increased the proportion of animals pregnant on Day 7. When ovaries from transgenic mice were transplanted into ovariectomized normal littermates, the recipients exhibited normal vaginal cycles and responded to mating by vaginal cytology changes consistent with pseudopregnancy. In contrast, ovariectomized transgenic females bearing transplants of ovaries from normal mice had slightly prolonged estrous cycles and failed to become pseudopregnant after mating. Plasma progesterone levels on Days 2 and 7 p.c. in normal females with transgenic ovaries were not different from plasma progesterone levels measured in normal females into which normal ovaries had been transplanted. Twice-daily injections of 100 micrograms of prolactin (PRL) in saline or in polyvinylpyrrolidone starting on the evening of Day 2 p.c. were able to rescue luteal function. The proportion of PRL-injected transgenic animals that were pregnant on Day 7 was significantly higher than that of saline-injected transgenic controls and resembled the pregnancy rate of normal animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626717     DOI: 10.1095/biolreprod52.5.1162

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

Review 1.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Effects of overexpression of growth hormone-releasing hormone on the hypothalamo-pituitary-gonadal function in the mouse.

Authors:  L Debeljuk; R W Steger; J C Wright; J Mattison; A Bartke
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

3.  Lactotroph hyperplasia in the pituitaries of female mice expressing high levels of bovine growth hormone.

Authors:  S Vidal; L Stefaneanu; K Thapar; R Aminyar; K Kovacs; A Bartke
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

Review 4.  Somatotropic Axis, Pace of Life and Aging.

Authors:  Andrzej Bartke
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

5.  Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1.

Authors:  Sylwia Słuczanowska-Głąbowska; Maria Laszczyńska; Katarzyna Piotrowska; Wojciech Głąbowski; John J Kopchick; Andrzej Bartke; Magda Kucia; Mariusz Z Ratajczak
Journal:  J Ovarian Res       Date:  2012-07-02       Impact factor: 4.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.